Newsroom
Keep up with the latest
Featured
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Epigenetic editors are a gentler form of gene editing
February 24, 2025
The Economist
Epigenetic editors are a gentler form of gene editing
February 24, 2025
Media Center
Press Release
Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences
November 5, 2026
Read Now
Press Release
Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences
November 5, 2026
Read Now
Press Release
Scribe Therapeutics to Present Updated Data on PCSK9-Targeting Epigenetic Silencing and LPA-Targeting Gene Editing Programs at American Heart Association (AHA) Scientific Sessions 2026
November 4, 2026
Read Now
Press Release
Scribe Therapeutics to Present Updated Data on PCSK9-Targeting Epigenetic Silencing and LPA-Targeting Gene Editing Programs at American Heart Association (AHA) Scientific Sessions 2026
November 4, 2026
Read Now
Media
Another proof point from CIRM-supported research
October 7, 2026
California Institute for Regenerative Medicine
Read Now
Press Release
Another proof point from CIRM-supported research
October 7, 2026
California Institute for Regenerative Medicine
Read Now
Media
Can Geneticists Fight Disease by Targeting ‘Nurture’ Instead of ‘Nature’?
September 8, 2026
The New York Times
Read Now
Press Release
Can Geneticists Fight Disease by Targeting ‘Nurture’ Instead of ‘Nature’?
September 8, 2026
The New York Times
Read Now
Blog